• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2012 Fiscal Year Final Research Report

Development of Nitric oxide traffic protein as a novel drug againstischemic diseases

Research Project

  • PDF
Project/Area Number 22790162
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeSingle-year Grants
Research Field Medical pharmacy
Research InstitutionKumamoto University

Principal Investigator

ISHIMA Yu  熊本大学, 薬学部, 助教 (00457590)

Project Period (FY) 2010 – 2012
Keywords薬物動態学 / ドラッグデリバリーシステム
Research Abstract

S-Nitrosated human serum albumin (SNO-HSA) is useful in preventing liverischemia/reperfusion injury, and SNO-HSA should thus be able to prevent cell injury duringliver transplantation. However, the potential protective effect of SNO-HSA on acombination of cold and warm ischemia, which is obligatory when performing livertransplantation, has not been examined. Our results indicate that a combination of SNO-HSAand UW solution can be used to prevent the two types of ischemia. Therefore, SNO-HSA-addedUW solution could be very useful in transplantation, because the previously imposedconstraints on preservation time can be removed. This is a great advantage in a situationas the present one with increased utilization of scarce donor organs for more recipients

  • Research Products

    (36 results)

All 2013 2012 2011 2010

All Journal Article (19 results) (of which Peer Reviewed: 19 results) Presentation (12 results) Patent(Industrial Property Rights) (5 results)

  • [Journal Article] UW solution improved with highanti-apoptotic activity byS-nitrosated human serum albumin2013

    • Author(s)
      IshimaY, Shinagawa T, Yoneshige S,Kragh-Hansen U, Ohya Y, Inomata Y,Kai T, Otagiri M, Maruyama T.
    • Journal Title

      Nitric Oxide

      Volume: 30 Pages: 36-42

    • Peer Reviewed
  • [Journal Article] Albumin domain II mutant with highbilirubin binding affinity has agreat potential as serum bilirubinexcretion enhancer forhyperbilirubinemia treatment2013

    • Author(s)
      Minomo A, Ishima Y, ChuangVT, Suwa Y, Kragh-Hansen U, NarisokoT, Morioka H, Maruyama T, Otagiri M
    • Journal Title

      Biochim Biophys Acta

      Volume: 1830 Pages: 2917-23.

    • Peer Reviewed
  • [Journal Article] p-Cresyl sulfate causes renaltubular cell damage by inducingoxidative stress by activation ofNADPH oxidase2013

    • Author(s)
      Watanabe H, Miyamoto Y,Honda D, Tanaka H, Wu Q, Endo M,Noguchi T, Kadowaki D, Ishima Y,Kotani S, Nakajima M, Kataoka K,Kim-Mitsuyama S, Tanaka M, FukagawaM, Otagiri M, Maruyama T.
    • Journal Title

      Kidney Int

      Volume: 83 Pages: 582-92.

    • Peer Reviewed
  • [Journal Article] A human serum albumin-thioredoxinfusion protein preventsexperimental contrast-inducednephropathy2013

    • Author(s)
      Kodama A, Watanabe H, TanakaR, Tanaka H, Chuang VT, Miyamoto Y,Wu Q, Endo M, Hamasaki K, Ishima Y,Fukagawa M, Otagiri M, Maruyama T.
    • Journal Title

      Kidney Int

      Volume: 83 Pages: 446-54.

    • Peer Reviewed
  • [Journal Article] S-nitrosated α-1-acidglycoprotein kills drug-resistantbacteria and aids survival in sepsis2013

    • Author(s)
      WatanabeK, Ishima Y, Akaike T, Sawa T, KurodaT, Ogawa W, Watanabe H, Suenaga A,Kai T, Otagiri M, Maruyama T.
    • Journal Title

      FASEB J

      Volume: 27 Pages: 391-8.

    • Peer Reviewed
  • [Journal Article] Elucidation of the therapeuticenhancer mechanism ofpoly-S-nitrosated human serum albuminagainst multidrug-resistant tumor inanimal models2012

    • Author(s)
      Ishima Y, Hara M,Kragh-Hansen U, Inoue A, Suenaga A,Kai T, Watanabe H, Otagiri M, MaruyamaT.
    • Journal Title

      J Control Release

      Volume: 164 Pages: 1-7.

    • Peer Reviewed
  • [Journal Article] A uremic toxin,3-carboxy-4-methyl-5-propyl-2-furanpropionate induces cell damage toproximal tubular cells via thegeneration of a radical intermediate2012

    • Author(s)
      Miyamoto Y, Ishima Y,Otagiri M, Maruyama T.
    • Journal Title

      Biochem Pharmacol

      Volume: 84 Pages: 1207-1214

    • Peer Reviewed
  • [Journal Article] Interaction between twosulfate-conjugated uremic toxins,p-cresyl sulfate and indoxyl sulfate,during binding with human serumalbumin2012

    • Author(s)
      Watanabe H, Miyamoto Y,Ishima Y, Otagiri M, Maruyama T.
    • Journal Title

      Drug Metab Dispos

      Volume: 40 Pages: 1423-1428.

    • Peer Reviewed
  • [Journal Article] S-guanylation of human serum albuminis a unique posttranslationalmodification and results in a novelclass of antibacterial agents2012

    • Author(s)
      Ishima Y,Akaike T, Maruyama T, Otagiri M.
    • Journal Title

      J PharmSci

      Volume: 101 Pages: 3222-3229.

    • Peer Reviewed
  • [Journal Article] Quantitative evaluation of the role ofcysteine and methionine residues inthe antioxidant activity of humanserum albumin using recombinantmutants2012

    • Author(s)
      Ishima Y, Maruyama T, Otagiri M.
    • Journal Title

      IUBMB Life.

      Volume: 64 Pages: 450-454.

    • Peer Reviewed
  • [Journal Article] S-Nitrosated human serum albumindimer is not only a novel anti-tumordrug but also a potentiator foranti-tumor drugs with augmented EPReffects2012

    • Author(s)
      Ishima Y, Maeda H, MaruyamaT, Otagiri M.
    • Journal Title

      Bioconjug Chem.

      Volume: 23 Pages: 264-271.

    • Peer Reviewed
  • [Journal Article] Biological characteristics of twolysines on human serum albumin in thehigh-affinity binding of 4Z,15Z-bilirubin-IX α revealed byphage display2011

    • Author(s)
      Minomo A, Ishima Y,Kragh-Hansen U, Maruyama T, OtagiriM.
    • Journal Title

      FEBS J

      Volume: 278 Pages: 4100-4111.

    • Peer Reviewed
  • [Journal Article] Cellular uptake mechanisms andresponses to NO transferred frommono- and poly-S-nitrosated humanserum albumin2011

    • Author(s)
      Ishima Y, Yoshida F,Akaike T, Maruyama T, Otagiri M.
    • Journal Title

      Free Radic Res

      Volume: 45 Pages: 1196-1206.

    • Peer Reviewed
  • [Journal Article] Human serum albumin-thioredoxinfusion protein with long bloodretention property is effective insuppressing lung injury2011

    • Author(s)
      Furukawa M, Chuang VT, Ishima Y,Maruyama T, Otagiri M.
    • Journal Title

      J ControlRelease

      Volume: 154 Pages: 189-195.

    • Peer Reviewed
  • [Journal Article] Albumin fusion of thioredoxin--theproduction and evaluation of itsbiological activity for potentialtherapeutic applications2010

    • Author(s)
      kuta S,Chuang VT, Ishima Y, Maruyama T,Otagiri M.
    • Journal Title

      J ControlRelease

      Volume: 147 Pages: 17-23.

    • Peer Reviewed
  • [Journal Article] The critical role of nitric oxidesignaling, via proteinS-guanylation and nitrated cyclicGMP, in the antioxidant adaptiveresponse2010

    • Author(s)
      Fujii S, Okamoto T,Ahtesham AK, Ishima Y, Motohashi H,Yamamoto M, Akaike T.
    • Journal Title

      J Biol Chem

      Volume: 285 Pages: 23970-23984.

    • Peer Reviewed
  • [Journal Article] One-step preparation ofS-nitrosated human serum albuminwith high biological activities2010

    • Author(s)
      Ishima Y, Hiroyama S, Kragh-HansenU, Maruyama T, Sawa T, Akaike T, KaiT, Otagiri M.
    • Journal Title

      Nitric Oxide

      Volume: 23 Pages: 121-127.

    • Peer Reviewed
  • [Journal Article] Genetically engineered mannosylatedhuman serum albumin as a versatilecarrier for liver-selectivetherapeutics2010

    • Author(s)
      Hirata K, Maruyama T,Watanabe H, Ishima Y, Hashida M,Otagiri M.
    • Journal Title

      J Control Release

      Volume: 145 Pages: 9-16.

    • Peer Reviewed
  • [Journal Article] Hirata K, Maruyama T,Watanabe H, Ishima Y, Hashida M,Otagiri M.2010

    • Author(s)
      Katayama N, Nakajou K, Ishima Y, IkutaS, Yokoe JI, Yoshida F, Suenaga A,Maruyama T, Kai T, Otagiri M.
    • Journal Title

      Nitric Oxide

      Volume: 22 Pages: 259-265.

    • Peer Reviewed
  • [Presentation] ヒト血清アルブミンドメイン II によるビリルビン尿中排泄促進作用2012

    • Author(s)
      小田切 優樹 1,2,3)、蓑毛 藍 3)、異島 優 3)、 成底 徹 3)、 諏訪 喜昭 3)、渡邊 博志 3)、 森岡 弘志 3)、 丸山 徹3)
    • Organizer
      第28回日本 DDS 学会学術集会
    • Place of Presentation
      札幌コンベンションセンター(北海道)
    • Year and Date
      20120704-05
  • [Presentation] 高分子抗癌剤の腫瘍集積性を高める S -ニトロソ化アルブミンダイマーの EPR効果増強作用2012

    • Author(s)
      異島 優 1,2)、井上 亜希 1)、方 軍3)、前田 浩 4)、渡邊 博志 1,2)、小田切 優樹 1,3,4)、丸山 徹 1,2)
    • Organizer
      第28回日本 DDS 学会学術集会
    • Place of Presentation
      札幌コンベンションセンター(北海道)
    • Year and Date
      20120704-05
  • [Presentation] S-ニトロソ化に伴うα1-酸性糖タンパク質(AGP)の抗菌機能獲得と感染症治療への応用2012

    • Author(s)
      渡辺佳織 1, 異島 優 1, 2, 赤池孝章 3,澤 智裕 3, 黒田照夫 4, 小川和加野 4, 渡邊博志 1, 2, 甲斐俊哉 1, 5, 小田切優樹 1, 6, 7, 丸山徹 1, 2
    • Organizer
      第12回日本 NO 学会学術集会
    • Place of Presentation
      神戸国際会議場(兵庫県)
    • Year and Date
      20120629-30
  • [Presentation] S-ニトロソ化アルブミンにより抗アポトーシス効果を付与した改良型臓器保存液の開発2012

    • Author(s)
      異島 優 1,2、 品川 拓也 1、 米重 梓二 1、 甲斐 俊哉 1、 赤池 孝章 3、 小田切 優樹 1,4,5、丸山 徹 1,2
    • Organizer
      第12回日本 NO学会学術集会
    • Place of Presentation
      神戸国際会議場(兵庫県)
    • Year and Date
      20120629-30
  • [Presentation] p-Cresyl sulfate causes renal tubularcell damage by inducing oxidativestress through the activation of NADPHoxidaseHiroshi2012

    • Author(s)
      Hiroshi Watanabe1,2, Daisuke Honda1,Yohei Miyamoto1, Tsuyoshi Noguchi1,Daisuke Kadowaki1,2, Yu Ishima1,2,Motoko Tanaka3, Hisae Tanaka4,Masafumi Fukagawa4, Masaki Otagiri1,5and Toru Maruyama1,2
    • Organizer
      49th ERA-EDTA Congress, Paris 2012
    • Place of Presentation
      Paris(France)
    • Year and Date
      20120524-27
  • [Presentation] A uremic toxin,3-carboxy-4-methyl-5-propyl-2-furanpropionate accumulates inproximal tubular cells and inducescell damage through increasingoxidative stress2012

    • Author(s)
      Yohei Miyamoto1, Yasunori Iwao2,Katsumi Mera1, Hiroshi Watanabe1,3,Daisuke Kadowaki1,3, Yu Ishima1,Victor Tuan Giam Chuang4, KeizoSato5, Masaki Otagiri1.6 and ToruMaruyama1,3*
    • Organizer
      49th ERA-EDTACongress, Paris 2012
    • Place of Presentation
      Paris(France)
    • Year and Date
      20120524-27
  • [Presentation] S -ニトロソ化アルブミンダイマーはEPR 効果を増強する2012

    • Author(s)
      3、 前田 浩 4、 小田切 優樹 1,3,4、渡邊 博志 1,2、 丸山 徹 1
    • Organizer
      日本薬剤学会第27年会
    • Place of Presentation
      神戸国際会議場(兵庫県)
    • Year and Date
      20120524-26
  • [Presentation] ブレオマイシン誘発肺線維症に対するアルブミン-チオレドキシン融合体の有用性評価2012

    • Author(s)
      田中 遼大 1、 小玉 あずさ 1、 異島 優 1,2、 田中 健一郎 1、 水島徹 1、渡邊 博志 1,2、 小田切 優樹1,3,4、 丸山 徹 1,2
    • Organizer
      日本薬剤学会第27年会
    • Place of Presentation
      神戸国際会議場(兵庫県)
    • Year and Date
      20120524-26
  • [Presentation] 新規翻訳後修飾体である S -グアニル化アルブミンは抗菌効果を発揮する2012

    • Author(s)
      異島 優 1,2、 星野 瞳 1、 品川 拓也 1、 小田切 優樹 1,3,4、 渡邊 博志 1,2、丸山 徹 1,2
    • Organizer
      本薬剤学会第27年会
    • Place of Presentation
      神戸国際会議場(兵庫県)
    • Year and Date
      20120524-26
  • [Presentation] アルギニンペプチドを利用した細胞膜透過型アルブミンの設計と評価2012

    • Author(s)
      濱崎 慶輔 1、 渡邊 博志 1,2、 弥永 直樹 1、 國安 明彦 3、 異島 優1,2、 小田切 優樹 1,3,4、 丸山 徹 1,2
    • Organizer
      日本薬剤学会第27年会
    • Place of Presentation
      神戸国際会議場(兵庫県)
    • Year and Date
      20120524-26
  • [Presentation] ファージディスプレイ法を用いた尿毒症 物 質 3-carboxy-4-methyl-5-propyl-2-furan (CMPF)高親和性アルブミン変異体の設計2012

    • Author(s)
      西村 知晃 1、 蓑毛 藍 1、 異島 優1,2、 末永 綾香 1、 渡邊 博志 1,2、森岡 弘志 1、 小田切 優樹 1,3,4、 丸山 徹 1,2
    • Organizer
      日本薬剤学会第27年会
    • Place of Presentation
      神戸国際会議場(兵庫県)
    • Year and Date
      20120524-26
  • [Presentation] In vivo ファージディスプレイ法を用いた新規腎送達ペプチドの探索2012

    • Author(s)
      弥永 直樹 1、 渡邊 博志 1,2、 濱崎慶輔 1、 國安 明彦 3、 異島 優 1,2、小田切 優樹 1,3,4、 丸山 徹 1,2
    • Organizer
      日本薬剤学会第27年会
    • Place of Presentation
      神戸国際会議場(兵庫県)
    • Year and Date
      20120524-26
  • [Patent(Industrial Property Rights)] 腎臓集積性を示すペプチド、薬物2012

    • Inventor(s)
      渡邊博志
    • Industrial Property Rights Holder
      ニプロ株式会社
    • Industrial Property Number
      特願 2012-097763
    • Filing Date
      2012-04-23
  • [Patent(Industrial Property Rights)] 細胞膜透過性を有する製剤、細胞膜透過性組成物及び薬物輸送方法2012

    • Inventor(s)
      渡邊博志
    • Industrial Property Rights Holder
      ニプロ株式会社
    • Industrial Property Number
      特願 2012-097762
    • Filing Date
      2012-04-23
  • [Patent(Industrial Property Rights)] S-ニトロソ化α1-酸性糖タンパク質を含有する抗菌剤2011

    • Inventor(s)
      異島 優
    • Industrial Property Rights Holder
      ニプロ株式会社
    • Industrial Property Number
      P111N21023
    • Filing Date
      2011-05-23
  • [Patent(Industrial Property Rights)] 抗癌剤増感剤2011

    • Inventor(s)
      異島 優
    • Industrial Property Rights Holder
      ニプロ株式会社
    • Industrial Property Number
      P111N21022
    • Filing Date
      2011-03-29
  • [Patent(Industrial Property Rights)] 高リガンド親和性アルブミン変異体の製造方法2010

    • Inventor(s)
      異島 優
    • Industrial Property Rights Holder
      異島 優
    • Patent Publication Number
      特開2010-172277
    • Acquisition Date
      2010-08-12

URL: 

Published: 2014-08-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi